Eric C. Klawiter, MD

Neurology Massachusetts General Hospital, Boston, MA 
multiple sclerosis
"Eric Klawiter"
Mean distance: 20.48 (cluster 46)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Fox RJ, Coffey CS, Conwit R, et al. (2018) Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis. The New England Journal of Medicine. 379: 846-855
Klawiter EC, Bove R, Elsone L, et al. (2017) High risk of postpartum relapses in neuromyelitis optica spectrum disorder. Neurology
Bove R, Elsone L, Alvarez E, et al. (2017) Female hormonal exposures and neuromyelitis optica symptom onset in a multicenter study. Neurology(R) Neuroimmunology & Neuroinflammation. 4: e339
Fox RJ, Coffey CS, Cudkowicz ME, et al. (2016) Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis. Contemporary Clinical Trials
Duval T, McNab JA, Setsompop K, et al. (2015) In vivo mapping of human spinal cord microstructure at 300 mT/m. Neuroimage
Kremer S, Renard F, Achard S, et al. (2015) Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder. Jama Neurology. 72: 815-22
Kim HJ, Paul F, Lana-Peixoto MA, et al. (2015) MRI characteristics of neuromyelitis optica spectrum disorder: an international update. Neurology. 84: 1165-73
Klawiter EC, Ceccarelli A, Arora A, et al. (2015) Corpus callosum atrophy correlates with gray matter atrophy in patients with multiple sclerosis. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 25: 62-7
Klawiter EC. (2013) Current and new directions in MRI in multiple sclerosis. Continuum (Minneapolis, Minn.). 19: 1058-73
Naismith RT, Xu J, Klawiter EC, et al. (2013) Spinal cord tract diffusion tensor imaging reveals disability substrate in demyelinating disease. Neurology. 80: 2201-9
See more...